Abstract 1857P
Background
The COVID-19 pandemic has been closely associated with a decline in mental health. The goal of this study was to identify the degree of distress of cancer patients before and after the pandemic and to find out if COVID-19 worsened the mental health of cancer patients.
Methods
A self-rated survey was conducted for 2 groups of patients at The Todua Clinic, Tbilisi, Georgia twice: at the peak of pandemic and again 6 months after the pandemic. Study included adult cancer patients, with solid tumors, over 18 years of age, receiving chemotherapy, being able to understand and answer the questions in written English. Event Scale-Revised (IES-R) test was implemented to measure Post-Traumatic Stress Disorder (PTSD). Total IES-R score of 33 or over signifies the likely presence of PTSD.
Results
Study enrolled total of 195 patients, 103 patients - during and 92 - after the pandemic. 3 independent and 5 dependent variables were created. Independent variables were: 1. IES-R score ≥24 ( y=1 if score ≥ 24, y=0 if score ≤ 24); 2. IES-R score≥ 33 (y=1 if score ≥ 33, y=0 if score ≤ 33); 3. IES-R score 37 (y= 1 if score ≤ 37, y=0 f score ≤ 37). Five dependent variables were: time, type of disease, stage, sex, and marital status. We created 3 regression models with independent and dependent variables (model 1: independent variable was IES-R score ≥24, model 2 independent variable was - IES-R score ≥ 33, model 3 IES-R score ≥ 33). We observed improvement in IES-R scores in the post-pandemic period: In model 1 - results improved by 20%, In model 2 - 16%, and in model 3 – 14%. Female and married individuals had better results in both periods. We calculated the data and observed that all dependent variables other than the disease type and the disease stage had a significant impact on IES-R scores.
Conclusions
Our findings showed a significant difference in IES-R scores in patients before and after the COVID-19 pandemic, with notable improvement in the post-COVID period. We also observed that sex, disease stage, marital status, and disease stage affected IES-R scores. We conclude that COVID-19 worsened the mental health of cancer patients. Our study highlighted the need for efforts to better integrate psychosocial support into cancer treatment.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1594P - End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Presenter: Ellis Slotman
Session: Poster session 05
1595P - Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Presenter: Silvia Buriolla
Session: Poster session 05
1596P - Exploring the economic impact of palliative care in oncology at the end of life
Presenter: Sarah Gomes
Session: Poster session 05
1597P - Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Presenter: Conor Moloney
Session: Poster session 05
1598P - Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer
Presenter: Hyun Jeong Shim
Session: Poster session 05
1599P - Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Presenter: Alessandro Leonetti
Session: Poster session 05
1600P - Sarcopenia, depression, and poor health perception among cancer patients registered in an oncology center in Pakistan
Presenter: Sobia Yaqub
Session: Poster session 05
1601P - Relationship between CT and ultrasonography-based sarcopenia and hematologic toxicity in patients with cancer receiving chemotherapy
Presenter: Gurkan Guner
Session: Poster session 05
1602P - Simulation training for compassionate extubation in the pediatric intensive care unit
Presenter: Nicole Fernandez
Session: Poster session 05
1603P - The ability of the LACE index to predict 30-day readmissions in oncology patients
Presenter: Burcu Ulas Kahya
Session: Poster session 05